UNSPSC 51401904: Fasiplon

This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C13H15N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XCA050IPGB, chemically known as 6-ethyl-7-methoxy-5-methyl-2-(5-methyl-1,2,4-oxadiazol-3-yl)imidazo(1,2-a)pyrimidine. but generally known as fasiplon, which bears US NIH Compound Identifier 208954. European Medicines Agency schedules Fasiplon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07514MIG.

UNSPSC 51401904 Fasiplon, a Commodity code, represents pharmaceutical products and chemical compounds procured by state and local health departments and county health agencies for community health and emergency response initiatives. The code covers specialized medical supplies and deactivation systems used in overdose prevention and substance-abuse intervention programs. State and local buyers under this code include county health departments and public health authorities managing naloxone distribution and drug disposal infrastructure.

Seminole County, Florida has solicited naloxone and drug deactivation systems through an IFB (Invitation for Bid) process, with the opportunity posted June 30, 2026, and responses due July 26, 2023. The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit unit costs for each line item, provide drug-free workplace certification and E-Verify compliance documentation, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with a one-year renewal option, includes a three-month probationary period, and is potentially funded through FEMA, bringing Clean Air Act and Federal Water Pollution Control Act compliance requirements.